In the Era of CFTR Modulators-Where do we go from here?

PDF icon CNMC Ped Pulmonology 12.6.24.pdf


Learning objectives:

  • Review pathophysiology of cystic fibrosis (CF)
  • Analyze mechanism and efficacy of currently available cystic fibrosis transmembrane conductance regulator (CFTR) modulators 
  • Evaluate benefits and concerns of available CFTR modulators
Session date: 
12/06/2024 - 8:00am to 9:00am EST
Location: 
Virtual
United States
  • 1.00 AMA PRA Category 1 Credit

Please login or register to take this course.
Faculty List: 
Program Director(s)

Jenny Lew, MD

has no relevant financial relationships to disclose at this time.

Deepa Rastogi, MD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Jessica Lundeen, PharmD, BCPPS

has no relevant financial relationships to disclose at this time.